Related Experiment Video
Updated: Apr 22, 2026
10:28
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
9.4K
Inhibitory effect of b-AP15 on the 20S proteasome
Li Huang1, Katherine Jung2, Chin Ho Chen3
1Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. li.huang@duke.edu.
Biomolecules
|October 16, 2014
Summary
The small molecule b-AP15 inhibits the 26S proteasome by targeting deubiquitination. This study reveals b-AP15 also directly inhibits the 20S proteasome core, indicating dual-site proteasome inhibition.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Biology
Background:
- The 26S proteasome is a crucial cellular machine for protein degradation, composed of 19S regulatory and 20S core particles.
- The small molecule b-AP15 was previously identified as an inhibitor targeting the deubiquitination activity of the 19S regulatory particle.
- Understanding the full inhibitory spectrum of b-AP15 is essential for its therapeutic potential.
Purpose of the Study:
- To investigate the direct inhibitory effects of b-AP15 on the 20S proteasome core.
- To compare the potency of b-AP15 against both the 19S regulatory and 20S core proteasome components.
Main Methods:
- Biochemical assays were employed to assess the activity of the 20S proteasome core.
- Enzyme kinetics were used to determine the inhibitory concentration of b-AP15 on the 20S proteasome.
Main Results:
- The small molecule b-AP15 was found to directly inhibit the catalytic activity of the 20S proteasome core.
- The potency of b-AP15 against the 20S proteasome core was comparable to its previously reported inhibition of the 19S regulatory particles.
Conclusions:
- b-AP15 exhibits dual-site inhibition of the 26S proteasome, affecting both the 19S regulatory and 20S core particles.
- These findings expand the understanding of b-AP15's mechanism of action and its potential as a proteasome inhibitor.
Related Concept Videos
01:17The Proteasome Structure
2.2K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
2.2K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
02:18The Proteasome
7.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
7.7K
02:18The Proteasome
3.9K
3.9K
01:25Inhibitors of Bacterial Protein Synthesis
93
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
93
01:19Allosteric Proteins-ATCase
4.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.8K